Gilead Sciences, Inc. (GILD) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Gilead Sciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.816 Good afternoon, everyone, and welcome to Gilead's third quarter 2025 earnings conference 00:00:04.816 -- 00:00:08.440 call. My name is Rebecca, and I'll be today's host. 00:00:08.440 -- 00:00:12.665 In a moment, we'll begin our prepared remarks, followed by our Q&A session. 00:00:12.665 -- 00:00:17.810 To ask a question, press star one. To withdraw your question, press star two. 00:00:17.810 -- 00:00:22.475 Now, I'll hand the call over to Jackie Ross, Senior Vice President of Treasury and Investor 00:00:22.475 -- 00:00:24.317 Relations. 00:00:24.317 -- 00:00:29.135 Thank you, Rebecca. Just after market closed today, we issued a press release with earnings 00:00:29.135 -- 00:00:32.641 results for the third quarter of 2025. The 00:00:32.641 -- 00:00:36.987 press release, slides, and supplementary data are available on the investor section of 00:00:36.987 -- 00:00:39.631 our website at Gilead.com. 00:00:39.631 -- 00:00:43.457 The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel 00:00:43.457 -- 00:00:48.465 O'Day, our Chief Commercial Officer, Joanna Mercier, our Chief Medical Officer, Dietmar 00:00:48.465 -- 00:00:52.327 Berger, and our Chief Financial Officer, Andrew Dickinson. 00:00:52.327 -- 00:00:56.774 to that, we'll open the call to Q&A, where the team will be joined by Cindy Peretti, 00:00:56.774 -- 00:01:01.842 the Executive Vice President of KITE. Let me remind you that we will be making forward-looking 00:01:01.842 -- 00:01:06.831 statements. Please refer to slide two regarding the risks and uncertainties relating 00:01:06.831 -- 00:01:12.019 to forward-looking statements that could cause actual results to differ materially. 00:01:12.019 -- 00:01:15.705 With that, I'll turn the call over to D...